Kwality Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹157.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.28 per cent from ₹123.44 crore. This corresponds to a year-on-year *(YoY) growth of 35.81 per cent.
Operating Profit
Operating Profit stands at ₹38.76 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.10 per cent from ₹29.12 crore. This corresponds to a year-on-year *(YoY) growth of 49.71 per cent.
PBDT
PBDT stands at ₹36.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 35.89 per cent from ₹27.17 crore. This corresponds to a year-on-year *(YoY) growth of 52.81 per cent.
Profit Before Tax
Profit Before Tax stands at ₹31.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.66 per cent from ₹22.35 crore. This corresponds to a year-on-year *(YoY) growth of 66.02 per cent.
Net Profit
Net Profit stands at ₹25.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 58.19 per cent from ₹16.00 crore. This represents a 74.79 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Kwality Pharmaceuticals Ltd News
Kwality Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Kwality Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Kwality Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Kwality Pharmaceuticals Ltd Financial Reports
Kwality Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Kwality Pharma | -3.39% | 4.82% | 34.89% | 38.51% | 133.57% | 130.83% |
| Panacea Biotec | 1.51% | 1.34% | 15.04% | 28.00% | 12.77% | -19.15% |
| Unichem Labs. | -0.04% | -5.41% | -5.82% | 2.26% | -24.89% | -40.42% |
| Morepen Labs. | 0.68% | 3.30% | 2.13% | 0.73% | 0.55% | -33.80% |
| Sai Parenteral's | -1.85% | 0.80% | -0.30% | 19.30% | 19.30% | 19.30% |
| Solara Active | 1.35% | -2.20% | 16.15% | 21.90% | 8.23% | 16.52% |
| Titan Biotech | -2.11% | 13.31% | -1.24% | 91.32% | 129.27% | 406.74% |
Company Info
Company Information
Executive Director & MD : Ramesh Arora
E D & Wholetime Director : Ajay Arora
Executive Director / Whole Time Director / CFO : Aditya Arora
E D & Wholetime Director : Geeta Arora
E D & Wholetime Director : Anju Arora
Independent Non Exe. Director : Kartik Kapur
Independent Non Exe. Director : Prashanth Vellanki
Independent Non Exe. Director : Vinod Kumar Sharma
Company Sec. & Compli. Officer : Gurpreet Kaur
Independent Non Exe. Director : Bhavesh Mahajan
Independent Non Exe. Director : Preet Mohinder S Bedi